<p>This study delves into the critical role of corporate governance in fostering research and development (R&amp;D) stability in Taiwanese firms, addressing a gap in existing research by examining how a strong Corporate Governance influences R&amp;D expenditure volatility. Utilizing a survey database of Taiwanese companies, we explore the moderating effect of a firm's risk-taking to transfer pricing across multi-international enterprise on this relationship. Additionally, we investigate how the mainly corporate governance variables affect motives for using transfer pricing and cash flow, as well as the influence of ownership structure. By employing system GMM to estimate a dynamic model, we examine the relationship between R&amp;D expenditure volatility and idiosyncratic volatility, incorporating several key components through a difference-in-difference method. The empirical results provide convincing evidence that good corporate governance practices mitigate R&amp;D fluctuations, constrain related-party transactions or cash flow, and have statistically significant negative impacts on R&amp;D expenditure volatility. Furthermore, transfer pricing and cash flow positively moderate these effects. These findings are robust across multiple sensitivity tests and highlight the potential benefits of transparency in financial statements for regulatory authorities.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

The influence of corporate governance on the volatility of R&D investment: an empirical study on its relationship with firm performance

  • Mu-Shun Wang

摘要

This study delves into the critical role of corporate governance in fostering research and development (R&D) stability in Taiwanese firms, addressing a gap in existing research by examining how a strong Corporate Governance influences R&D expenditure volatility. Utilizing a survey database of Taiwanese companies, we explore the moderating effect of a firm's risk-taking to transfer pricing across multi-international enterprise on this relationship. Additionally, we investigate how the mainly corporate governance variables affect motives for using transfer pricing and cash flow, as well as the influence of ownership structure. By employing system GMM to estimate a dynamic model, we examine the relationship between R&D expenditure volatility and idiosyncratic volatility, incorporating several key components through a difference-in-difference method. The empirical results provide convincing evidence that good corporate governance practices mitigate R&D fluctuations, constrain related-party transactions or cash flow, and have statistically significant negative impacts on R&D expenditure volatility. Furthermore, transfer pricing and cash flow positively moderate these effects. These findings are robust across multiple sensitivity tests and highlight the potential benefits of transparency in financial statements for regulatory authorities.